(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Crystal Gateway Marriott

23 sep 2026 8:15 a.m. - 25 sep 2026 12:45 p.m.

1700 Richmond Highway, Arlington, VA 22202, USA

Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Registrarse
Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

Volver a Agenda

Session 3 Tracks 1 and 2: Regulatory Considerations of Novel Conjugates: Translational and Clinical Pharmacology Perspectives

Session Chair(s)

Louis St. L. O'Dea, MD

Louis St. L. O'Dea, MD

Independent Consultant, United States

Patrik Andersson, PHD

Patrik Andersson, PHD

Principal Scientist, Discovery Safety Specialist, AstraZeneca R&D, Sweden

Session 3 Tracks 1 and 2: Regulatory Considerations of Novel Conjugates: Translational and Clinical Pharmacology Perspectives

¿Tiene una cuenta?

Registrarse

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.